Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Incidence of AKI in Critically-ill COVID -19 Patients, A Single Centre Retrospective Study From March 2020 Till September 2021.

NCT05467956 is registered in ClinicalTrials.gov with Sultan Qaboos University as lead sponsor.

NCT NCT05467956
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05467956 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Incidence of AKI in Critically-ill COVID -19 Patients, A Single Centre Retrospective Study From March 2020 Till September 2021.
Lead sponsor
Sultan Qaboos University
Phase
Observational
Overall status
Completed
Start date
March 1, 2020
Completion date
July 1, 2022
Enrollment
286 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, covid-19, critically ill